These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 31089925)

  • 21. A nanowire-based liquid biopsy method using cerebrospinal fluid cell-free DNA for targeted management of leptomeningeal carcinomatosis.
    Choi W; Cho Y; Park SY; Hwang KH; Han JY; Lee Y
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):213-222. PubMed ID: 32705364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and Future Directions.
    Lee DW; Lee KH; Kim JW; Keam B
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cauda Equina Syndrome Secondary to Leptomeningeal Carcinomatosis of Gastroesophageal Junction Cancer.
    Alkhotani A; Alrishi N; Alhalabi MS; Hamid T
    Case Rep Neurol; 2016; 8(1):87-91. PubMed ID: 27239185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome after whole brain radiotherapy alone in intracranial leptomeningeal carcinomatosis from solid tumors.
    Gani C; Müller AC; Eckert F; Schroeder C; Bender B; Pantazis G; Bamberg M; Berger B
    Strahlenther Onkol; 2012 Feb; 188(2):148-53. PubMed ID: 22231633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged overall survival of patients with leptomeningeal carcinomatosis from nonsmall cell lung cancer.
    Ju Y; Sun S; Wang J; Jiao S
    J Cancer Res Ther; 2016 Oct; 12(Supplement):126-129. PubMed ID: 27721269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Afatinib combined with cetuximab for lung adenocarcinoma with leptomeningeal carcinomatosis.
    Lin CH; Lin MT; Kuo YW; Ho CC
    Lung Cancer; 2014 Sep; 85(3):479-80. PubMed ID: 24999085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis.
    Liao BC; Lee JH; Lin CC; Chen YF; Chang CH; Ho CC; Shih JY; Yu CJ; Yang JC
    J Thorac Oncol; 2015 Dec; 10(12):1754-61. PubMed ID: 26334749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of whole brain radiation therapy for leptomeningeal carcinomatosis.
    Hirano Y; Konishi K; Ejima Y
    Int J Clin Oncol; 2020 Jul; 25(7):1432-1439. PubMed ID: 32274614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective Analysis of Cerebrospinal Fluid Profiles in 228 Patients with Leptomeningeal Carcinomatosis : Differences According to the Sampling Site, Symptoms, and Systemic Factors.
    Shim Y; Gwak HS; Kim S; Joo J; Shin SH; Yoo H
    J Korean Neurosurg Soc; 2016 Nov; 59(6):570-576. PubMed ID: 27847569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of bevacizumab and erlotinib combination for leptomeningeal carcinomatosis after failure of erlotinib.
    Ariyasu R; Horiike A; Koyama J; Saiki M; Sonoda T; Kawashima Y; Takano N; Oguri T; Nishikawa S; Kitazono S; Yanagitani N; Ohyanagi F; Nishio M
    Anticancer Drugs; 2017 Jun; 28(5):565-567. PubMed ID: 28225456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of commonly mutated genes in leptomeningeal carcinomatosis.
    Congur I; Koni E; Onat OE; Tokcaer Keskin Z
    PeerJ; 2023; 11():e15250. PubMed ID: 37096065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival Patterns for Patients with Resected N2 Non-Small Cell Lung Cancer and Postoperative Radiotherapy: A Prognostic Scoring Model and Heat Map Approach.
    Deng W; Xu T; Xu Y; Wang Y; Liu X; Zhao Y; Yang P; Liao Z
    J Thorac Oncol; 2018 Dec; 13(12):1968-1974. PubMed ID: 30194035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of Leptomeningeal Carcinomatosis Diagnosis, Management and Outcomes in Patients with Solid Tumors Over a Decade of Experience.
    Rinehardt H; Kassem M; Morgan E; Palettas M; Stephens JA; Suresh A; Ganju A; Lustberg M; Wesolowski R; Sardesai S; Stover D; Vandeusen J; Cherian M; Prieto Eibl MDPG; Miah A; Alnahhas I; Giglio P; Puduvalli VK; Ramaswamy B; Williams N; Noonan AM
    Eur J Breast Health; 2021 Oct; 17(4):371-377. PubMed ID: 34651117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal Fluid Penetration Rate and Efficacy of Afatinib in Patients with EGFR Mutation-positive Non-small Cell Lung Cancer with Leptomeningeal Carcinomatosis: A Multicenter Prospective Study.
    Tamiya A; Tamiya M; Nishihara T; Shiroyama T; Nakao K; Tsuji T; Takeuchi N; Isa SI; Omachi N; Okamoto N; Suzuki H; Okishio K; Iwazaki A; Imai K; Hirashima T; Atagi S
    Anticancer Res; 2017 Aug; 37(8):4177-4182. PubMed ID: 28739703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leptomeningeal enhancement in magnetic resonance imaging predicts poor prognosis in lung adenocarcinoma patients with leptomeningeal metastasis.
    Gao X; Pan R; Chen M; Zhao J; Zhong W; Wang H; Si X; Zhang X; Zhang L; Xu Y; Wang M
    Thorac Cancer; 2022 Apr; 13(7):1059-1066. PubMed ID: 35238486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leptomeningeal carcinomatosis as primary manifestation of pancreatic cancer.
    Trinh VT; Medina-Flores R; Chohan MO
    J Clin Neurosci; 2016 Aug; 30():124-127. PubMed ID: 26972704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI based neuroanatomical segmentation in breast cancer patients: leptomeningeal carcinomatosis vs. oligometastatic brain disease vs. multimetastastic brain disease.
    Mayinger M; Reibelt A; Borm KJ; Ettl J; Wilkens JJ; Combs SE; Oechsner M; Duma MN
    Radiat Oncol; 2019 Sep; 14(1):170. PubMed ID: 31533742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leptomeningeal carcinomatosis originating from advanced gastric cancer--a report of three cases and review of the literatures.
    Kusumoto T; Kimura Y; Sugiyama M; Ohta M; Tsutsumi N; Sakaguchi Y; Ikejiri K; Oki E; Saeki H; Morita M; Ikeda T; Furuta T; Maehara Y
    Fukuoka Igaku Zasshi; 2013 Nov; 104(11):456-63. PubMed ID: 24620642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leptomeningeal carcinomatosis and brain metastases in gastroesophageal carcinoma: a real-world analysis of clinical and pathologic characteristics and outcomes.
    Baccili Cury Megid T; Baskurt Z; Ma LX; Barron CC; Farooq A; Saltiel MP; Wang X; Bach Y; Ayoama H; Jang RW; Chen E; Veit-Haibach P; Wang B; Kalimuthu S; Cotton J; Wong R; Mesci A; Elimova E
    J Neurooncol; 2024 Mar; 167(1):111-122. PubMed ID: 38372902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.